Aripiprazole for the tic symptoms in a child receiving atomoxetine treatment for ADHD.
Yu
Shu-Han
SH
Chou
Jen-Yu
JY
Robson
Debbie
D
Chen
Vincent Chin-Hung
VC
D018759:Adrenergic Uptake Inhibitors / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D000068180:Aripiprazole; D000069445:Atomoxetine Hydrochloride; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D002648:Child; D006801:Humans; D008297:Male; D010879:Piperazines / Q000627:therapeutic use*; D011437:Propylamines / Q000009:adverse effects; D015363:Quinolones / Q000627:therapeutic use*; D013981:Tic Disorders / Q000139:chemically induced / Q000188:drug therapy*
D018759:Adrenergic Uptake Inhibitors; D014150:Antipsychotic Agents; D010879:Piperazines; D011437:Propylamines; D015363:Quinolones; D000069445:Atomoxetine Hydrochloride; D000068180:Aripiprazole